Medicine
Pantoprazole 40 mg powder for oral suspension
Pantoprazole 40 mg powder for oral suspension is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store pantoprazole sodium for delayed-release oral suspension at 20°C to 25°C…
Key facts
- Active ingredient (INN)
- Pantoprazole
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 1 for suspension, 30 for suspension, 30 packets
- Manufacturers
- Ajanta PharmaIndiaAmerican Health Packaging
- Origin register
- US FDA, United States
- Storage
- Store pantoprazole sodium for delayed-release oral suspension at 20°C to 25°C (68°F to77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A02BC02 Pantoprazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 February 2023
- Identifiers
- RxCUI 763306DailyMed set ID 423dac8b-bb1e-4456-9b6e-913c028b11bc, 90963a38-f629-45a4-bddd-9e13a55fe0f7NDC 60687-767, 27241-256Application ANDA217416
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 for suspension in 1 packet | 27241-256-11 | Ajanta PharmaIndia | 9 February 2023 |
| 30 for suspension in 1 carton | 27241-256-38 | Ajanta PharmaIndia | 9 February 2023 |
| 30 packet in 1 carton / 1 for suspension in 1 packet | 60687-767-27 | American Health Packaging | 1 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pantoprazole
Clinical summary
Pantoprazole is a proton pump inhibitor indicated for pROTONIX is a proton pump inhibitor (PPI) indicated for the following, among other approved uses. MedsAcross supplies Pantoprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PantoprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Protonix Delayed-Release prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Controloc Control: European public assessment report (EPAR) · European Medicines Agency
- Pantozol Control: European public assessment report (EPAR) · European Medicines Agency
Need Pantoprazole 40 mg powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.